Headquartered in Boston, Entrada is a private company that completed its Series A in December 2018. Entrada's family of investors includes 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund, and Agent Capital.
At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platform to yield treatments for patients in need.
What we all have in common is our devotion to patients and our passion for science.
Our Values
-
Humanity
We genuinely care about patients and about one another
-
Tenacity
We’re relentless and persistent in the pursuit of developing therapies for patients
-
Creativity
We’re creative problem solvers
-
Collaboration
We’re more than the sum of our parts
-
Curiosity
We’ve got a growth mindset
Join our team if you share our values, our devotion to patients and our passion for science
Meet Our Entradans
-
At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments.
Dipal Doshi, President and Chief Executive Officer -
What makes Entrada a great place to work is its high-energy environment, complemented by our employees’ shared desire to make a difference in science and on patients.
Leo Qian, Co-founder and Head, Discovery Research -
It is very exciting to innovate daily; making scientific discoveries with the talented, innovative and motivated scientists at Entrada.
BK Choi, Senior Principal Scientist
Current Openings
Scientist, Bioanaltyical and Mass Spectrometry at Entrada Therapeutics
Boston, MA
Learn more
